Clinical trial Recruiting at 2 sites Interventional Ages 65 and up

Helping older Latinos in underserved areas use helpful devices to do more at home

Official title: Tech Enabled Functional Health: Bridging Primary Care Gaps for Older Latinos With Functional Disabilities in Underserved Communities

Run by University of Puerto Rico · NCT06425510 · Data updated 2026-11-12

This project tests a culturally tailored assistive-technology program called VIVE-AT to help older Latino adults with disabilities improve daily functioning and quality of life.

More Aging trials

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment76 (estimated)
SponsorUniversity of Puerto Rico
Academic / other
Locations2 sites (San Juan and 1 other locations)
StatusRecruiting
StartedAugust 1, 2026
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedNovember 9, 2026
Trial IDNCT06425510 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Spanish-speaking Latino adults aged 65 or older with a physical function impairment living independently in the community in Puerto Rico.

Probably not a fit

Individuals with significant cognitive impairment or those already in nursing/group homes may be less likely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study will refine the VIVE-AT program with input from a community advisory board and focus groups, then randomize 76 Spanish-speaking adults aged 65+ with functional impairments in Puerto Rico to receive the VIVE-AT intervention in primary care or to a waitlist control with regular calls. All participants will continue to receive usual clinic care. The intervention uses simple assistive devices and technology-supported strategies delivered through primary care and community health workers to support daily activities. The trial will measure changes in functional difficulties and quality of life over thematically defined time points. Safety and adherence will be monitored, and the approach aims to increase home participation and reduce dependence on formal care.

Why it matters

Potential benefit: If successful, participants may experience improved daily functioning and quality of life through culturally appropriate assistive technology support.

How similar studies have gone: Prior work suggests assistive technology can improve functioning, but tailored programs for Latino older adults in primary care are limited and require demonstration of efficacy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Spanish speaking Latino adults ≥65 years
* With a physical function impairment (PROMIS-HAQ T-Score ≤45)
* Living independently in the community (not requiring supervision to perform their daily living activities)
* Self-reported ability to participate in a 6 weeks of group intervention
* Having no plans to move for the next 12 months

Exclusion Criteria:

* Currently residing in a nursing or group home
* Receiving home healthcare services
* Having a significant cognitive impairment as evidenced by a score ≤23 in the Mini Mental State Examination (MMSE)

Where it's running

  • University of Puerto Rico Medical Sciences Campus
    San Juan, Puerto Rico
    Recruiting
  • HealthproMed Foundation, Inc.
    San Juan, Puerto Rico
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.